Return to Listing

1 result(s) for

PI Name Protocol # Title
Jacqueline Vuky STUDY00016676 A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080